Name
DISCUSSION : Safety and efficacy risks to de-risk degradation and degradation targets
Date & Time
Wednesday, March 3, 2021, 11:45 AM - 12:25 PM
Ian Churcher Andrew Zhang
Description

· How will resistance play a part in small molecule degraders?
·· Will degradation strategies lead to autoimmune responses when considering non-oncogenic
targets?
·· How can we improve toxicity profiles?

Virtual Session Link